Anorectal stricture in 102 patients with Crohn's disease: Natural history in the era of biologics

Alimentary Pharmacology and Therapeutics

Volumn 40, Issue 7, 2014, Pages 796-803

  Brochard, C ^a   Siproudhis, L ^a   Wallenhorst, T ^a   Cuen, D ^a   D'Halluin, P N ^a   Garros, A ^a   Bretagne, J F ^a   Bouguen, G ^a  

^a UNIVERSITÉ DE RENNES 1   (France)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA INHIBITOR; BIOLOGICAL FACTOR; IMMUNOSUPPRESSIVE AGENT;

ADULT; ANORECTAL DISEASE; ARTICLE; CANCER INCIDENCE; CANCER PROGNOSIS; COLON CROHN DISEASE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE CLASSIFICATION; DISEASE DURATION; FEMALE; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; NONPARAMETRIC TEST; PHENOTYPE; RECTUM CARCINOMA; RECTUM RESECTION; SEPSIS; ADENOCARCINOMA; ADOLESCENT; ANUS NEOPLASMS; COMPLICATION; CONSTRICTION, PATHOLOGIC; CROHN DISEASE; PATHOLOGY; RECTAL FISTULA; YOUNG ADULT;

ADENOCARCINOMA; ADOLESCENT; ADULT; ANUS NEOPLASMS; BIOLOGICAL FACTORS; CONSTRICTION, PATHOLOGIC; CROHN DISEASE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; RECTAL FISTULA; YOUNG ADULT;

EID: 84908092942     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.12894     Document Type: Article

References (16)

1. Gray BK, Lockhartmummery HE, Morson BC. Crohn's disease of the anal region. Gut 1965; 6: 515-24.
2. Rutgeerts P. Review article: treatment of perianal fistulizing Crohn's disease. Aliment Pharmacol Ther 2004; 20(Suppl 4): 106-10.
3. Bouguen G, Siproudhis L, Gizard E, et al.Long-term outcome of perianal fistulizing Crohn's disease treated with infliximab. Clin Gastroenterol Hepatol 2013; 11: 975-81.
4. Bouguen G, Siproudhis L, Bretagne JF, et al. Nonfistulizing perianal Crohn's disease: clinical features, epidemiology, and treatment. Inflamm Bowel Dis 2010; 16: 1431-42.
5. Fields S, Rosainz L, Korelitz BL, et al. Rectal strictures in Crohn's disease and coexisting perirectal complications. Inflamm Bowel Dis 2008; 14: 29-31.
6. Hughes LE. Clinical classification of perianal Crohn's disease. Dis Colon Rectum 1992; 35: 928-32.
7. Galandiuk S, Kimberling J, Al-Mishlab TG, et al. Perianal Crohn disease. Ann Surg 2005; 241: 796-802.
8. Linares L, Moreira LF, Andrews H, et al. Natural history and treatment of anorectal strictures complicating Crohn's disease. Br J Surg 1988; 75: 653-5.
9. Gasche C, Scholmerich J, Brynskov J, et al. A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis 2000; 6: 8-15.
10. Harvey RF, Bradshaw JM. A simple index of Crohn's-disease activity. Lancet 1980; 8: 514.
11. Irvine EJ. Usual therapy improves perianal Crohn's disease as measured by a new disease activity index. McMaster IBD Study Group. J Clin Gastroenterol 1995; 20: 27-32.
12. Jorge JM, Wexner SD. Etiology and management of fecal incontinence. Dis Colon Rectum 1993; 36: 77-97.
13. Knowles CH, Eccersley AJ, Scott SM, et al. Linear discriminant analysis of symptoms in patients with chronic constipation: validation of a new scoring system (KESS). Dis Colon Rectum 2000; 43: 1419-26.
14. Panés J, Bouzas R, Chaparro M, et al. Systematic review: the use of ultrasonography, computed tomography and magnetic resonance imaging for the diagnosis, assessment of activity and abdominal complications of Crohn's disease. Aliment Pharmacol Ther 2011; 34: 125-45.
15. Gecse KB, Bemelman W, Kamm MA, et al. A global consensus on the classification, diagnosis and multidisciplinary treatment of perianal fistulising Crohn's disease. Gut 2014; in press doi: 10.1136/gutjnl-2013-306709 [Epub ahead of print]
16. Slesser AA, Bhangu A, Bower M, et al. A systematic review of anal squamous cell carcinoma in inflammatory bowel disease. Surg Oncol. 2013; 22: 230-7.